{
  "created_at": "Thu Nov 18 6:39:50 +0000 2021",
  "id_str": "1461211758798983171",
  "full_text": "Two mRNA vaccines, Moderna and Pfizer-BioNtech, performed best https://t.co/lJPMhVUS3Z",
  "display_text_range": [
    0,
    86
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/lJPMhVUS3Z",
        "expanded_url": "https://econ.st/3oA9DH7",
        "display_url": "econ.st/3oA9DH7",
        "indices": [
          63,
          86
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 30,
  "favorite_count": 107,
  "possibly_sensitive": false,
  "original_created_at": "Thu Nov 18 05:56:45 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "2つのmRNAワクチン、ModernaとPfizer-BioNtechのパフォーマンスが最も良かった https://t.co/lJPMhVUS3Z"
    },
    {
      "locale": "zh",
      "full_text": "Moderna和Pfizer-BioNtech这两种mRNA疫苗表现最好 https://t.co/lJPMhVUS3Z"
    },
    {
      "locale": "zh-Hant",
      "full_text": "Moderna和Pfizer-BioNtech這兩種mRNA疫苗表現最好 https://t.co/lJPMhVUS3Z"
    }
  ]
}